Introducing 
Protocol
Cell Genesis is a biotechnology company with over 11 years of experience in cell therapy research. Having a team of experienced medical doctors and scientists leading the company, focuses on the ground breaking research and development in Stem Cell Technology. Our groundbreaking research and development demonstrates our dedication to advance scientific knowledge and technology in medical field. The source of CEXCI is natural and safe, to ensure the safety and efficacy of CEXCI is crucial in the field of biotechnology.
Cell Enhancement Research Protocols |
This is our integrated solution to improve aging cells with our proprietary proteins that we have isolated to benefit the function of the host own stem cells to replicate and differentiate further. We will have different protocols for each system.
* Cell Enhancement Face Protocol (CEXCI-FX1)
This protocol uses the power of our proprietary cell proteins to benefit the skin by slowing sign of ageing, encourage growth of new skin cells to speed up all the regeneration process that our skin needs.
* Cell Enhancement Cervical Spine Protocol (CEXCI-SPX1)
Inflammatory condition of the spine, often results in pain and discomfort to patients. It’s worth noting the development and application of CEXCI protocol as a complementary approach for patients. The potential of CEXCI in addressing chronic inflammation is our goal in this clinical studies.
* Cell Enhancement Knee Protocol (CEXCI-KX1)
Inflammation in the knee, often associated with conditions like arthritis or injuries, can cause pain, stiffness and reduced mobility. Strengthening the muscles that support the knee is crucial for proper joint function. Clinical studies will be essential to establish the effectiveness of CEXCI Technology for knee-related issues.
The development of CEXCI Technology could offer a non-invasive alternative to conventional approaches. By promoting muscle healing and reducing muscle spasms, it could have a positive impact on the quality of life of individuals suffering from muscle injuries and spasms.
Diabetes, both type 1 and type 2, is a chronic condition that affects millions of people worldwide. Further research and clinical studies are necessary to address all the aspect of diabetes, such as slowing down the progression of Diabetes, and prevent or delay the onset of complications.
Stroke is a serious medical condition that can have long-lasting consequences on an individual’s health and quality of life. It is essential to conduct rigorous clinical studies to establish the effectiveness of CEXCI Technology. This will provide the necessary evidence to support its implementation as a viable option for post stroke patients.
CEXCI Technology approaches the ability of regenerating neurons, potential to restore function and improve quality of life for individuals living with the condition. Ongoing research and clinical studies will be crucial to validate the efficacy of this protocols.
Kidney deterioration is a serious health concern worldwide. Developing strategies by using CEXCI Protocol to slow down the progress of this deterioration is crucial. Regulatory approvals and rigorous research in CEXCI Kidney Protocol are part of our company pipeline.
Heart Failure is a condition in which the heart is unable to pump blood efficiently. It is typically a chronic and progressive condition that can have a significant impact on a person’s quality of life. Our research studies is to find definite solutions for heart failure and its associated complications with CEXCI Protocols.
COPD and lung fibrosis are chronic respiratory conditions characterised by progressive lung damage and impaired lung function. The potential of CEXCI in repairing damaged lung tissues is an exciting research prospect. Continued research will be the key in realising the full potential of CEXCI.
Finding innovative approaches to support liver function and promote regeneration is crucial in improving outcomes for liver failure patients. The potential of CEXCI-LDX1 for liver regeneration needs continued research and development.